We are live on
!
Find out more
NAM
Needelman Asset Management Portfolio holdings
AUM
$46M
1-Year Est. Return
8.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$38.8M
AUM Growth
+$1.47M
(+3.9%)
Cap. Flow
+$677K
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
38
New
1
Increased
11
Reduced
19
Closed
1
Avg Time Held
14
quarters
Top 10 Avg Time Held
7.6
quarters
Top 20 Avg Time Held
9.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NCR Voyix
VYX
|
+$1.4M |
| 2 |
The Kraft Heinz Company
KHC
|
+$17.7K |
| 3 |
GE Aerospace
GE
|
+$10.7K |
| 4 |
AT&T
T
|
+$10.3K |
| 5 |
Apple
AAPL
|
+$8.87K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$520K |
| 2 |
Elevance Health
ELV
|
+$67.4K |
| 3 |
UnitedHealth
UNH
|
+$61K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$20.8K |
| 5 |
Markel Group
MKL
|
+$19.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Financials | 22.74% |
| 3 | Technology | 15.59% |
| 4 | Consumer Staples | 12.17% |
| 5 | Industrials | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Merck
MRK
$351B
| $859K | 2.21% |
14,054
-104
| -0.7% | -$6.33K |
2013 Q3
15 quarters
|
|
|
27
AT&T
T
$170B
| $851K | 2.19% |
29,863
+351
| +1% | +$10.3K |
2013 Q2
16 quarters
|
|
28
Yum! Brands
YUM
$39B
| $846K | 2.18% |
11,470
+70
| +0.6% | +$4.87K |
2013 Q2
16 quarters
|
|
29
Chipotle Mexican Grill
CMG
$41.4B
| $841K | 2.17% |
101,000
| – | – |
2016 Q1
5 quarters
|
|
30
Bristol-Myers Squibb
BMY
$122B
| $819K | 2.11% |
14,700
| – | – |
2013 Q2
16 quarters
|
|
31
Wells Fargo
WFC
$248B
| $763K | 1.96% |
13,766
-100
| -0.7% | -$5.36K |
2013 Q2
16 quarters
|
|
32
Mondelez International
MDLZ
$77.4B
| $736K | 1.89% |
17,040
+45
| +0.3% | +$2.03K |
2013 Q2
16 quarters
|
|
33
AbbVie
ABBV
$481B
| $729K | 1.88% |
10,057
-75
| -0.7% | -$5.04K |
2013 Q2
16 quarters
|
|
34
Verizon
VZ
$193B
| $713K | 1.84% |
15,974
+31
| +0.2% | +$1.44K |
2013 Q2
16 quarters
|
|
35
Yum China
YUMC
$14.1B
| $450K | 1.16% |
11,400
| – | – |
2016 Q4
2 quarters
|
|
36
IBM
IBM
$213B
| $269K | 0.69% |
1,826
| – | – |
2013 Q2
16 quarters
|
|
|
37
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
| – | – |
-16,210
| Closed | -$520K | – |
|
Similar funds
PRHC
BC
SCPM
SAM
BCP
AVA
GG
SM
Needelman Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Needelman Asset Management held 38 positions worth $38.8M, up 3.9% from $37.4M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Needelman Asset Management's Q2 2017 filing shows 1 new, 11 increased, 19 reduced and 1 closed positions. Its largest new stake was NCR Voyix: 55,216 shares worth $1.38M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $520K.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Financials and Technology.
- Needelman Asset Management's largest Q2 2017 buy was NCR Voyix: 55,216 shares worth $1.38M.
- Needelman Asset Management added most to The Kraft Heinz Company in Q2 2017, an estimated $17.7K increase.
- Needelman Asset Management's biggest Q2 2017 reduction was Elevance Health, cutting an estimated $67.4K.
- Needelman Asset Management fully exited Teva Pharmaceutical Industries Limited in Q2 2017, selling an estimated $520K.
- Needelman Asset Management's ten largest holdings make up 38% of its $38.8M portfolio in Q2 2017.
- Needelman Asset Management opened 1 new position and closed 1 in Q2 2017.
- Needelman Asset Management's portfolio value rose 3.9% quarter-over-quarter to $38.8M.
Based on Needelman Asset Management's 13F filing for Q2 2017, filed 7 Jul 2017.